WO2002072794A3 - Proteines de la superfamille des immunoglobulines - Google Patents

Proteines de la superfamille des immunoglobulines Download PDF

Info

Publication number
WO2002072794A3
WO2002072794A3 PCT/US2002/009052 US0209052W WO02072794A3 WO 2002072794 A3 WO2002072794 A3 WO 2002072794A3 US 0209052 W US0209052 W US 0209052W WO 02072794 A3 WO02072794 A3 WO 02072794A3
Authority
WO
WIPO (PCT)
Prior art keywords
immunoglobulin superfamily
igsfp
superfamily proteins
provides
proteins
Prior art date
Application number
PCT/US2002/009052
Other languages
English (en)
Other versions
WO2002072794A2 (fr
Inventor
Henry Yue
Yuming Xu
Kavitha Thangavelu
Bridget A Warren
Y Tom Tang
Brendan M Duggan
Uyen K Tran
Mariah R Baughn
Cynthia D Honchell
Neil Burford
Ian J Forsythe
Junming Yang
Patricia M Mason
Original Assignee
Incyte Genomics Inc
Henry Yue
Yuming Xu
Kavitha Thangavelu
Bridget A Warren
Y Tom Tang
Brendan M Duggan
Uyen K Tran
Mariah R Baughn
Cynthia D Honchell
Neil Burford
Ian J Forsythe
Junming Yang
Patricia M Mason
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc, Henry Yue, Yuming Xu, Kavitha Thangavelu, Bridget A Warren, Y Tom Tang, Brendan M Duggan, Uyen K Tran, Mariah R Baughn, Cynthia D Honchell, Neil Burford, Ian J Forsythe, Junming Yang, Patricia M Mason filed Critical Incyte Genomics Inc
Priority to US10/471,449 priority Critical patent/US20040097711A1/en
Priority to EP02726671A priority patent/EP1409655A4/fr
Priority to AU2002257088A priority patent/AU2002257088A1/en
Priority to CA002440618A priority patent/CA2440618A1/fr
Priority to JP2002571850A priority patent/JP2004533222A/ja
Publication of WO2002072794A2 publication Critical patent/WO2002072794A2/fr
Publication of WO2002072794A3 publication Critical patent/WO2002072794A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

L'invention concerne des protéines de la superfamille des immunoglobulines humaines (IGSFP) et des polynucléotides identifiant et codant les IGSFP. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes ainsi que des antagonistes. L'invention concerne également des méthodes de diagnostic, de traitement ou de prévention de troubles associés à l'expression aberrante d'IGSFP.
PCT/US2002/009052 2001-03-12 2002-03-12 Proteines de la superfamille des immunoglobulines WO2002072794A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US10/471,449 US20040097711A1 (en) 2002-03-12 2002-03-12 Immunoglobulin superfamily proteins
EP02726671A EP1409655A4 (fr) 2001-03-12 2002-03-12 Proteines de la superfamille des immunoglobulines
AU2002257088A AU2002257088A1 (en) 2001-03-12 2002-03-12 Immunoglobulin superfamily proteins
CA002440618A CA2440618A1 (fr) 2001-03-12 2002-03-12 Proteines de la superfamille des immunoglobulines
JP2002571850A JP2004533222A (ja) 2001-03-12 2002-03-12 免疫グロブリンスーパーファミリータンパク質

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US27524901P 2001-03-12 2001-03-12
US60/275,249 2001-03-12
US31681001P 2001-08-31 2001-08-31
US60/316,810 2001-08-31
US32397701P 2001-09-21 2001-09-21
US60/323,977 2001-09-21
US34844701P 2001-10-26 2001-10-26
US60/348,447 2001-10-26
US34388001P 2001-11-02 2001-11-02
US60/343,880 2001-11-02

Publications (2)

Publication Number Publication Date
WO2002072794A2 WO2002072794A2 (fr) 2002-09-19
WO2002072794A3 true WO2002072794A3 (fr) 2004-01-29

Family

ID=27540591

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/009052 WO2002072794A2 (fr) 2001-03-12 2002-03-12 Proteines de la superfamille des immunoglobulines

Country Status (5)

Country Link
EP (1) EP1409655A4 (fr)
JP (1) JP2004533222A (fr)
AU (1) AU2002257088A1 (fr)
CA (1) CA2440618A1 (fr)
WO (1) WO2002072794A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002074906A2 (fr) * 2001-03-16 2002-09-26 Eli Lilly And Company Proteines de mammiferes lp et reactifs associes
MXPA04001986A (es) * 2001-08-29 2004-06-07 Genentech Inc Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
CA2489803A1 (fr) 2002-06-20 2003-12-31 The Regents Of The University Of California Compositions et procedes de modulation de l'activite lymphocytaire
US8546541B2 (en) 2002-06-20 2013-10-01 Washington University Compositions and methods for modulating lymphocyte activity
CA2503125C (fr) 2002-10-25 2013-04-30 Hilary Clark Nouvelle composition et procedes pour le traitement de maladies auto-immunes
US20040109863A1 (en) * 2002-12-04 2004-06-10 Peter Emtage Methods of therapy and diagnosis using targeting of cells that express Ly-9
US20040248257A1 (en) * 2003-04-30 2004-12-09 The Scripps Research Institute SPEX compositions and methods of use
EP1812465B1 (fr) * 2004-11-12 2016-09-07 Genentech, Inc. Nouvelle composition et methodes permettant de traiter les maladies liees au systeme immunitaire
US8188232B1 (en) 2004-11-15 2012-05-29 Washington University In St. Louis Compositions and methods for modulating lymphocyte activity
US8303952B2 (en) 2009-06-08 2012-11-06 Washington University Methods for inducing in vivo tolerance
CN105188749B (zh) 2012-12-21 2017-12-19 西雅图基因公司 抗ntb‑a抗体及相关组合物和方法
MX2016003525A (es) 2013-09-17 2017-01-06 Univ Health Network (Uhn) Agentes dirigidos contra una interaccion cis de molecula de orientacion repulsiva a (rgma) /neogenina o balsas lipidicas y uso de los mismos en metodos de tratamiento.
EP2905622A1 (fr) * 2014-02-07 2015-08-12 Institut D'Investigaciones Biomédiques August Pi i Sunyer Diagnostic d'une maladie neurologique

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000029583A2 (fr) * 1998-11-19 2000-05-25 Incyte Pharmaceuticals, Inc. Proteines de la superfamille des immunoglobulines
JP2002538841A (ja) * 1999-03-18 2002-11-19 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ２７個のヒト分泌タンパク質
CA2391455A1 (fr) * 1999-12-01 2001-06-07 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides
AU6802801A (en) * 2000-03-01 2001-09-24 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP2004501623A (ja) * 2000-06-27 2004-01-22 キュラジェン　コーポレイション ポリヌクレオチドおよびそれによってコードされるポリペプチド
JP2005500815A (ja) * 2000-12-29 2005-01-13 キュラジェン コーポレイション タンパク質およびそれをコードする核酸
EP1402058A4 (fr) * 2001-06-05 2006-02-01 Exelixis Inc Dgk en tant que modulateurs du mecanisme d'action de p53 et procedes d'utilisation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] June 2001 (2001-06-01), NAGASE ET AL., XP002970308, accession no. NCBI Database accession no. (BAB47496) *
See also references of EP1409655A4 *

Also Published As

Publication number Publication date
EP1409655A4 (fr) 2005-04-06
EP1409655A2 (fr) 2004-04-21
JP2004533222A (ja) 2004-11-04
CA2440618A1 (fr) 2002-09-19
WO2002072794A2 (fr) 2002-09-19
AU2002257088A1 (en) 2002-09-24

Similar Documents

Publication Publication Date Title
WO2000029583A3 (fr) Proteines de la superfamille des immunoglobulines
WO2003027228A3 (fr) Recepteurs et proteines associees a une membrane
WO2002038602A3 (fr) Proteines secretees
WO2003048305A3 (fr) Recepteurs et proteines associees aux membranes
WO2002072794A3 (fr) Proteines de la superfamille des immunoglobulines
WO2002048337A3 (fr) Proteines secretees
WO2001098353A3 (fr) Proteines secretees
WO2003029437A3 (fr) Proteines secretees
WO2001079291A3 (fr) Proteines secretees
WO2003004615A3 (fr) Proteines secretees
WO2002097060A3 (fr) Proteines associees aux carbohydrates
WO2002094990A3 (fr) Recepteurs et proteines associees aux membranes
WO2002070669A3 (fr) Proteines secretees
WO2002086069A3 (fr) Proteines secretees
WO2003068943A3 (fr) Proteines secretees
WO2003054219A3 (fr) Proteines associees a des acides nucleiques
WO2002053719A3 (fr) Proteines associees au cytosquelette
WO2002026982A3 (fr) Proteines secretees
WO2003025130A3 (fr) Recepteurs et proteines associees a la membrane
WO2002066646A3 (fr) Proteines associees a la neurotransmission
WO2002057454A3 (fr) Proteines associees a une membrane et a des recepteurs
WO2003038052A3 (fr) Proteines associees aux acides nucleiques
WO2003087300A3 (fr) Proteines secretees
WO2002040671A3 (fr) Proteines de la superfamille des immunoglobulines
WO2002079441A3 (fr) Proteines secretees

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002571850

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 10471449

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2440618

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002726671

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2002726671

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002726671

Country of ref document: EP